Ealixir Saham

Ealixir Beban Bunga

Beban Bunga dari Ealixir (EAXR) pada 9 Agu 2026.

Beban Bunga

0,00USD

Terakhir Diperbarui:

Beban Bunga dari Ealixir adalah 2026 0,00 USD. Beban Bunga dari Ealixir adalah 2025 16.000,00 USD. Menurun % lebih rendah dibandingkan dengan tahun sebelumnya.
Access this data via the Eulerpool API

Ealixir Analisis saham

Apa yang dilakukan Ealixir? Ealixir Inc is a biotechnology company founded in 2012 by Dr. Nithin Rajan. Dr. Rajan earned his doctoral degree in biomedical science from the University of Ottawa and has over ten years of experience in the field of biomedical research. Ealixir Inc is an innovative firm specializing in the development of novel therapeutic technologies based on cell and proteomic research. Ealixir's goal is to help patients with serious or chronic illnesses by offering biological solutions that support the body's natural functions. Ealixir has developed the concept of "lifestyle medicine," aiming to develop treatments that not only combat diseases but also influence the patient's lifestyle to help them lead a healthier life. The company follows an integrative approach, combining the use of medications and other therapeutic approaches. Ealixir specializes in ingredients and technologies that have the potential to stimulate and activate the body to promote natural regenerative processes. One of Ealixir's significant products is the Arthritin system, which is used for the treatment of arthritis and pain. Arthritin utilizes a blend of pain relief, inflammation inhibitors, and regeneration promoters to effectively alleviate arthritis pain and reverse the damage caused by the disease to the joints. Ealixir is also a pioneer in the development of nano "in-minutes" technologies, where nanoparticles are used to actively transport active substances to specific target cells, thereby achieving results in minutes rather than hours. Another important product of Ealixir is Collagenix, a beauty product that uses a blend of collagen, vitamins, and minerals to improve skin structure and wrinkle depth. Ealixir also offers products for animal care and medicine. The company has developed a new product for wound care in pets using the Ealixir technology. The solution consists of antibacterial ingredients and promotes the growth of new tissue. Ealixir also focuses on researching dietary supplements that contribute to overall health and well-being. The company pays special attention to proteins, magnesium, and omega-3 fatty acids. The range includes CBD oil and support for restful sleep. Overall, Ealixir has established itself as a leading company in biomedical research and the development of innovative therapies. The company's products are at the forefront of technology and are developed and tested by a great team of researchers and scientists. The brand has experienced rapid growth in recent years and will undoubtedly achieve many successes in the future, benefiting both patients and animal lovers as well as people who value health and wellness. Ealixir adalah salah satu perusahaan paling populer di Eulerpool.

Pertanyaan yang Sering Diajukan tentang saham Ealixir

Di Eulerpool Anda dapat menemukan perkembangan historis lengkap Beban Bunga Ealixir sejak 2006 – dengan nilai tahunan, bagan, dan analisis detail.

Beban bunga mewakili biaya peminjaman. Beban bunga yang lebih tinggi dapat menunjukkan perusahaan yang sangat terleverage.

USD Beban Bunga adalah faktor kunci bagi investor. Perubahan metrik ini dapat menunjukkan fundamental yang membaik atau memburuk, secara langsung memengaruhi harga saham. Di Eulerpool, Anda dapat melacak Ealixir Beban Bunga secara historis dan real-time.

Access this data via the Eulerpool API

Laporan Laba Rugi — Ealixir

Semua Metrik Kunci — Ealixir